Oneview Healthcare PLC · ASX:ONE
Oneview Healthcare — H1 2026 Earnings Presentation
40 slides from Oneview Healthcare's earnings presentation, Aug 27, 2026
Slide 1: H1 2026 results: Executing on our path to scalable growth
For personal use only H A L F Y E A R R E S U LT S H1 2026 results Executing on our path to scalable growth Oneview Healthcare PLC · H1 2026 results 27 August 2026
Slide 2: Legal disclaimer
I M P O R TA N T N O T I C E Legal disclaimer For personal use only This presentation contains general information about the activities of Oneview Except as required by applicable law, neither Oneview, its related bodies Healthcare PLC (ABRN 610 611 768) (Oneview or Company) which is corporate, nor
Slide 3: Legal disclaimer (continued)
I M P O R TA N T N O T I C E Legal disclaimer (continued) For personal use only The information in this presentation is for general information only. This presentation contains forward looking This presentation is not intended to and does not constitute, form part of or contain an offer or invitatio
Slide 4: Speakers
Speakers For personal use only James Fitter Darragh Lyons Chief Executive Officer Chief Financial Officer Oneview Healthcare PLC · H1 2026 results 4
Slide 5: Agenda
Agenda For personal use only 01 Financial performance 02 Commercial momentum 03 Product and innovation 04 Outlook 05 Questions Oneview Healthcare PLC · H1 2026 results 5
Slide 6: Executing on our path to scalable growth
INVESTMENT HIGHLIGHTS Executing on our path to scalable growth For personal use only +13% 70% A$19m New −15% Recurring revenue Gross margin two-tranche Revenue channel Operating cash growth placement secured outflow €4.3m of recurring Up nine points from 61%. Cash of €7.2m (A$11.9m) Bedside Hub laun
Slide 7: H1 2026 at a glance
SCORECARD H1 2026 at a glance For personal use only Financial Commercial Product Revenue of €5.5m down 14% Four new logos in contract Bedside Hub certified by Epic or −9% on a constant currency basis negotiation and launched in May 2026 reflecting a lower non-recurring contribution Recurring revenue
Slide 8: Financial performance
For personal use only SECTION ONE Financial performance Oneview Healthcare PLC · H1 2026 results 8
Slide 9: Financial highlights
SIX MONTHS ENDED 30 JUNE 2026 Financial highlights For personal use only € millions H1 2026 H1 2025 Change 70% Recurring revenue 4.3 3.8 +13% Non-recurring revenue 1.2 2.5 −54% Total revenue 5.5 6.3 −14% Gross margin, up from 61% The shift towards higher-margin recurring revenue held Cost of sales (
Slide 10: Recurring revenue growth
REVENUE & GROSS MARGIN Recurring revenue growth For personal use only Recurring revenue grew 13% year on year. +20% H1 2026 H1 2025 €4.3m growth in recurring revenue on H1 2025 on a €3.8m constant currency basis 70% gross margin, up from 61% H1 2025 €6.3m total revenue Non-recurring Recurring €3.8m
Slide 11: Operating cost base
C A S H O P E R AT I N G E X P E N S E S Operating cost base For personal use only 9.0 100 8.5 Average headcount 8.0 95 7.5 7.0 90 6.5 6.0 85 H2 2024 H1 2025 H2 2025 H1 2026 Cash operating expenses, € millions, per half, left scale. Average headcount per half, right scale, orange. H2 2024 was the pe
Slide 12: Operating cash outflow
N E T C A S H U S E D I N O P E R AT I N G A C T I V I T I E S Operating cash outflow For personal use only €5.2m €4.8m €4.1m −15% H1 2026 against H1 2025 −22% across first halves since H1 2024 Operating cash outflow fell 15% against the first half of 2025, and has fallen in each of H1 2024 H1 2025
Slide 13: Capital position
BAL ANCE SHEET Capital position For personal use only € millions 30 June 31 Dec. 30 June 25 Change since Change since 26 25 31 Dec. 2025 30 June 2025 The March placement Cash and cash equivalents 7.2 4.6 8.2 +56% −12% A two-tranche institutional placement Trade and other receivables 2.3 4.7 3.1 −51%
Slide 14: The path to breakeven
O P E R AT I N G L E V E R A G E The path to breakeven For personal use only US access through Penetration in the Pricing power from Disciplined cost AI in the delivery Baxter and Epic existing customer Ovie savings model Bedside Hub base The Baxter partnership Significant upside remains The Ovie ec
Slide 15: Commercial momentum
For personal use only SECTION T WO Commercial momentum Oneview Healthcare PLC · H1 2026 results 15
Slide 16: A changing market creates opportunity
M A R K E T C O N D I T I O N S · U N I T E D S TAT E S A changing market creates opportunity For personal use only EpicTV temporarily slowed some decisions on our core platform while cost-conscious health systems weigh their options. Market evaluation The funding backdrop Faster to deploy Epic-cent
Slide 17: Commercial highlights
PROGRESS IN THE HALF Commercial highlights For personal use only Top-10 health system Four new logos in A new revenue channel GPO contract negotiation Bedside Hub launched in May 2026 Oneview was added to a national care 1 x Direct following certification by Epic, enabling communication agreement be
Slide 18: A dual-market commercial model
R O U T E TO M A R K E T A dual-market commercial model For personal use only CXP platform SMART-ROOM BUYERS Bedside Hub EPIC-FIRST BUYERS MyStay, Ovie and five patient-facing touchpoints: TV, tablet, Launched May 2026 on Epic certification, delivering whiteboard, door sign and MyStay Mobile. Epic M
Slide 19: Baxter funnel
PA R T N E R - S O U R C E D P I P E L I N E Baxter funnel For personal use only 131 36,375 open opportunities licensed beds represented S TA G E OPPS Develop 39 Qualify 55 Design 25 Validate 11 Negotiate 1 37 opportunities Full product set are at design stage or beyond. Care Experience Platform Dig
Slide 20: Certification reignited some stalled pipeline opportunities
B E D S I D E H U B P I P E L I N E S I N C E C E R T I F I C AT I O N Certification reignited some stalled pipeline opportunities For personal use only Epic certification has driven strong engagement: 9 of our 16 active opportunities were previously stalled and are now active again and the volume o
Slide 21: Epic TV Bedside Hub pipeline: licensed beds
EPICT V BEDSIDE HUB PIPELINE · LICENSED BEDS 16 opportunities, For personal use only 19,860 beds Stalled opportunity re-engaged Re-engaged and demonstrated Demonstration delivered pre UGM Integrated health system · Midwest 3,800 C O N C E N T R AT I O N Statewide health system · Midwest 3,500 Region
Slide 22: 50+ conversations, and a market actively reassessing
EPIC USER GROUP MEETING, MADISON 50+ conversations, and a For personal use only market actively reassessing Our first invitation to Epic's User Group Meeting has produced significant new engagement. Strong market Epic certification Competitive Momentum building validation strengthening displacement
Slide 23: A US$50bn federal program aimed at what we already do
M A R K E T O P P O R T U N I T Y · U N I T E D S TAT E S A US$50bn federal program FY2026 — FY2030 US$50b For personal use only aimed at what we already do The Rural Health Transformation Program funds telehealth, remote monitoring, digital infrastructure and workforce productivity, capabilities ou
Slide 24: Live endpoint growth
I N S TA L L E D B A S E Live endpoint growth For personal use only 15,500 15,092 M OV E M E N T I N H 1 2 0 2 6 14,880 15,000 Live at 31 Dec 2025 14,880 14,500 Endpoints deployed +693 14,000 Endpoints decommissioned −481 13,540 13,411 13,500 Live at 30 Jun 2026 15,092 13,000 693 endpoints deployed
Slide 25: A pressured market but a sales pipeline that has recently doubled
MARKET DYNAMICS · AUSTRALIA AND NEW ZEAL AND A pressured market but a sales For personal use only pipeline that has recently doubled Market under pressure Active bids, January to today Private hospital operators face constrained funding, thin January margins and consolidation, slowing discretionary
Slide 26: Customer acquisition timeline
NEW LOGOS SINCE 2023 Customer acquisition timeline For personal use only 2023 6 logos 2024 8 logos 2025 4 logos 2026 Four new logos currently in contract negotiations Total addressable ARR H1 €25.6m €16m at 4 endpoints per room at 2.5 endpoints per room At current average endpoint pricing. Oneview H
Slide 27: Product and innovation
For personal use only SECTION THREE Product and innovation Oneview Healthcare PLC · H1 2026 results 27
Slide 28: Bedside technology: a transformed value proposition
MARKET OPPORTUNITY Bedside technology: a transformed value proposition For personal use only The patient room is no longer a passive space; it is critical clinical infrastructure for the virtual care era. Nursing labour Burnout and retention HCAHPS and Oneview's virtual care economics Offloading doc
Slide 29: New front end: reimagining the digital environment of care
P L AT F O R M New front end: reimagining the digital environment of care For personal use only Modern experience Contemporary design system, improved T H E PAT I E N T R O O M P L AT F O R M accessibility, materially better usability. A complete modernisation of the Oneview patient experience, and
Slide 30: Innovation delivered in H1 2026
P R O D U C T A N D I N N O VAT I O N Innovation delivered in H1 2026 For personal use only Delivery across platform modernisation, AI, analytics and the Epic ecosystem, each with a commercial purpose. 01 02 03 04 Bedside Hub New front end Ovie evolution Data and analytics Epic-certified · launched
Slide 31: Delivering More, Faster: AI-Enabled Product Development
HOW WE BUILD Delivering More, Faster: AI-Enabled Product Development For personal use only A shared approach An autonomous AI harness The product and engineering teams have created a shared library of In parallel, an autonomous AI harness has been implemented, with a AI skills, to share knowledge, i
Slide 32: Outlook
For personal use only SECTION FOUR Outlook Oneview Healthcare PLC · H1 2026 results 32
Slide 33: Why Oneview is differentiated
COMPETITIVE POSITION Why Oneview is differentiated For personal use only Deep hospital Installed Clinical workflow Regulatory Customer quality and integrations infrastructure relevance requirements retention Our platform is wired into 15,092 live endpoints Clinicians use our Healthcare-grade 3 of th
Slide 34: H2 2026 priorities
OUTLOOK H2 2026 priorities For personal use only Commercial Financial Product Operations Convert late-stage Continue optimising the First deployments of the First deployments of opportunities operating cost base new front end from Bedside Hub September Drive expansions across Continue the strong ARR
Slide 35: Q&A
For personal use only SECTION FIVE Q &A Oneview Healthcare PLC · H1 2026 results 35
Slide 36: Appendix: Financial statements
For personal use only APPENDIX Financial statements Oneview Healthcare PLC · H1 2026 results 36
Slide 37: Statement of comprehensive income
APPENDIX · UNAUDITED Statement of comprehensive income For personal use only Six months ended 30 June · €'000 2026 2025 Revenue 5,485 6,342 Cost of sales (1,643) (2,497) Gross profit 3,842 3,845 Sales and marketing expenses (2,772) (2,437) Product development and delivery expenses (5,200) (6,202) Ge
Slide 38: Statement of financial position
APPENDIX · 30 JUNE 2026 UNAUDITED Statement of financial position For personal use only €'000 30 June 26 31 Dec. 25 €'000 30 June 26 31 Dec. 25 Intangible assets 618 666 Lease liabilities, non-current 808 880 Property, plant and equipment 998 1,062 Trade and other payables, non- 895 1,148 Research a
Slide 39: Statement of cash flows
APPENDIX · UNAUDITED Statement of cash flows For personal use only Six months ended 30 June · €'000 2026 2025 Receipts from customers 5,142 6,365 Payments to suppliers and staff (9,811) (11,628) Research and development tax credit received 595 444 Finance costs and income tax paid (23) (1) Net cash
Slide 40: Board of Directors and corporate information
APPENDIX Board of Directors For personal use only Corporate information Barbara Nelson Nashina Asaria Registered office Chair Non-executive Director 2nd Floor Avoca Court, Temple Road, Blackrock, Co. Dublin, Ireland Mark Cullen Michael Dowling Australian office Non-executive Director Non-executive D